KVUE Kenvue

Q3 2025 10-Q

Filed: Nov 3, 2025Period ending Sep 28, 2025

Health Care

Perfumes, Cosmetics & Other Toilet PreparationsSEC EDGAR

Kenvue (KVUE) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 3, 2025 for the fiscal period ending Sep 28, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q3 2025 10-Q

Management Discussion & Analysis

• Quarterly revenue $3.76B, down 3.5% YoY ($135M decrease from $3.9B)
• Gross profit margin up 59.1% vs 58.5% YoY; operating income down 3.8%

+4 more insights

Risk Factors

• Newly added risk: Transaction financing increasing K-C’s debt, potentially reducing liquidity and flexibility before closing
• Most materially updated risk: $1,136M termination fee added if Transaction terminated under certain conditions, increasing financial exposure

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$3.8B

Net Income

$398M

Net Margin

10.6%

Source: XBRL data from Kenvue Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other Kenvue Quarterly Reports

Q2 2025 10-Q

Get deeper insights on Kenvue

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.